Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) (METROmaJX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02630368
Recruitment Status : Recruiting
First Posted : December 15, 2015
Last Update Posted : October 2, 2017
Sponsor:
Collaborators:
National Cancer Institute, France
Fondation ARC
Information provided by (Responsible Party):
Institut Bergonié

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2018
Estimated Study Completion Date : September 2020